|4May 8, 4:58 PM ET

DelMar Pharmaceuticals, Inc. 4

4 · DelMar Pharmaceuticals, Inc. · Filed May 8, 2017

Insider Transaction Report

Form 4
Period: 2017-05-05
BACHA JEFFREY
CEO and President10% Owner
Transactions
  • Purchase

    Common Stock

    2017-05-05$2.20/sh+2,500$5,50041,645 total

Documents

1 file
  • 4
    f4050517bacha_delmarpharma.xmlPrimary

    OWNERSHIP DOCUMENT